Please Note: Microsoft has ended support of its older browsers as of January 2016. If you are seeing this message, you are viewing the site on an unsupported version of Internet Explorer (IE10 or older). To properly view this website, please upgrade your version of IE or access this site using a different browser. Thank you.
Sign InDues Join Privacy Contact Search
Home News Scrip

Scrip

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below.

John Lezcano
Corporate Account Manager
M: (631) 807-4971
John.lezcano@informa.com

Pharma intelligence | informa
P: (212) 652-2678
pharmaintelligence.informa.com

Scrip
Monday, January 18, 2021
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and...
Sunday, January 17, 2021
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's...
Friday, January 15, 2021
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
Friday, January 15, 2021
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a...
Friday, January 15, 2021
The French biotech's chances of competing with Aimmune's Palforzia in the peanut allergy market have been boosted after US regulators...
Friday, January 15, 2021
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of...
Friday, January 15, 2021
One year after the first cases of a novel coronavirus emerged in Wuhan, a team from the World Health Organization...
Friday, January 15, 2021
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up...
Thursday, January 14, 2021
Cipla sees an incremental revenue opportunity of up to $500m for its US franchise by fiscal 2025 and expects to...
Thursday, January 14, 2021
After years of setbacks, Novavax is on the cusp of success with its COVID-19 vaccine - but a rapid scale...